Ketotifen is protective against indomethacin-induced intestinal ulceration in the rat

Israel Journal of Medical Sciences

Volumn 32, Issue 5, 1996, Pages 312-315

  Zahavi, I ^a   Weizen, T ^a   Marcus, H ^a   Karmeli, F ^a   Dinari, G ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Indomethacin; Ketotifen; Leukotriene B4; NSAIDs; Prostaglandin E2; Small intestinal damage

Indexed keywords

COMPOSITION EFFECTS; DRUG PRODUCTS; GASTROENTEROLOGY; LIVING SYSTEMS STUDIES; PHYSIOLOGY; PROTEINS;

INDOMETHACIN INDUCED INTESTINAL ULCERATION; INFLAMMATORY BOWEL DISEASE; KETOTIFEN; SMALL INTESTINAL DAMAGE;

DRUG THERAPY;

HISTAMINE H1 RECEPTOR ANTAGONIST; INDOMETACIN; KETOTIFEN; LEUKOTRIENE B4; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTESTINE ULCER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SMALL INTESTINE; SMALL INTESTINE MUCOSA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DUODENAL ULCER; HISTAMINE H1 ANTAGONISTS; INDOMETHACIN; KETOTIFEN; LEUKOTRIENE B4; MALE; RATS; RATS, WISTAR;

EID: 0030152823     PISSN: 00212180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)